Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Subscribe To Our Newsletter & Stay Updated
